Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Jian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, Khung Keong Yeo, Kathryn Tan, Junya Ako, Rungroj Krittayaphong, Ru San Tan, Philip E Aylward, Sang Hong Baek, Jamshed Dalal, Alan Yean Yip Fong, Yi-Heng Li, Richard C O’Brien, Tien Siang Eric Lim, Si Ya Natalie Koh, Daniel J Scherer, Hayato Tada, Vernon Kang, Julie Butters & Stephen J Nicholls. (2020) Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects. Expert Opinion on Drug Metabolism & Toxicology 16:9, pages 837-851.
Read now
Read now
Yi-Chung Shih & Huan-Sheng Lin. (2017) Effectiveness of fixed-dose ezetimibe+simvastatin in real-life hypercholesterolaemia treatment: a retrospective observational study in Taiwan. Clinical Lipidology 12:1, pages 45-55.
Read now
Read now
Sajita Setia, Selwyn Sze-Wang Fung & David D Waters. (2015) Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vascular Health and Risk Management 11, pages 303-310.
Read now
Read now
Dujrudee Chinwong, Jayanton Patumanond, Surarong Chinwong, Khanchai Siriwattana, Siriluck Gunaparn, John Joseph Hall & Arintaya Phrommintikul. (2015) Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand. Therapeutics and Clinical Risk Management 11, pages 659-667.
Read now
Read now
Dujrudee Chinwong, Jayanton Patumanond, Surarong Chinwong, Khanchai Siriwattana, Siriluck Gunaparn, John Joseph Hall & Arintaya Phrommintikul. (2015) Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency. Therapeutics and Clinical Risk Management 11, pages 127-136.
Read now
Read now
Kevin Jameson, Qiaoyi Zhang, Changgeng Zhao, Dena Rosen Ramey, Andrew M. Tershakovec, Stephen W. Gutkin & Elizabeth Marrett. (2014) Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database. Current Medical Research and Opinion 30:4, pages 655-665.
Read now
Read now
Miao Hu, G Neil Thomas & Brian Tomlinson. (2011) Lipid disorders in Chinese populations. Clinical Lipidology 6:5, pages 549-562.
Read now
Read now
Jui-Chu Huang, Tao-Yu Lee, Miaw-Jene Liou, Chi-Min Lin, Dee Pei, Zhih-Cherng Chen, Rue-Tsuan Liu & Ching-Fai Kwok. (2011) Begin with the Real-world Patients of Non-goal-achieved Hypercholesterolemia in Taiwan through the Ezetimibe/Simvastatin Tablet – The BRAVO Study. Current Medical Research and Opinion 27:8, pages 1645-1651.
Read now
Read now
Loukianos S Rallidis, Christos Kotakos, Vassilios Sourides, Christos Varounis, Athanasios Charalampopoulos, Maria Zolindaki, Nikolaos Dagres, Costas Papadopoulos & Maria Anastasiou-Nana. (2011) Attainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dl and impact on prognosis of very high risk stable coronary patients: a 3-year follow-up. Expert Opinion on Pharmacotherapy 12:10, pages 1481-1489.
Read now
Read now
Alberico L. Catapano. (2009) Perspectives on low-density lipoprotein cholesterol goal achievement. Current Medical Research and Opinion 25:2, pages 431-447.
Read now
Read now
Articles from other publishers (50)
Yong Huo, Anastasia Lesogor, Cheol Whan Lee, Chern-En Chiang, Jorge Mena-Madrazo, Kian Keong Poh, Myung Ho Jeong, Pierre Maheux, Mengli Zhang, Suning Wei, Yajun Han & Yong Li. (2023) Efficacy and Safety of Inclisiran in Asian Patients. JACC: Asia.
Crossref
Crossref
Aimi Zafira Razman, Noorhida Baharudin, Noor Alicezah Mohd Kasim, Alyaa Al-Khateeb, Zaliha Ismail & Hapizah Nawawi. (2022) Undertreatment and Underachievement of LDL-C Target among Individuals with High and Very High Cardiovascular Risk in the Malaysian Community. Healthcare 10:12, pages 2448.
Crossref
Crossref
Tan Van Nguyen, Dieu Thi Thanh Tran, Trinh Thi Kim Ngo & Tu Ngoc Nguyen. (2022) Sex Difference in Control of Low-Density Lipoprotein Cholesterol in Older Patients after Acute Coronary Syndrome. Geriatrics 7:4, pages 71.
Crossref
Crossref
Jeongmin Lee, Sue Hyun Lee, Hyunah Kim, Seung‐Hwan Lee, Jae Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, Kun‐Ho Yoon, Hun‐Sung Kim & Ju Han Kim. (2020) Low‐density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real‐world evidence. Journal of Clinical Pharmacy and Therapeutics 46:1, pages 134-142.
Crossref
Crossref
Ji Bak Kim, Woo Hyuk Song, Jong Sung Park, Tae-Jin Youn, Yong Hyun Park, Shin-Jae Kim, Sung Gyun Ahn, Joon-Hyung Doh, Yun-Hyeong Cho & Jin Won Kim. (2021) A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia. PLOS ONE 16:1, pages e0245481.
Crossref
Crossref
Siin Kim, Sola Han, Pratik P. Rane, Yi Qian, Zhongyun Zhao & Hae Sun Suh. (2020) Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea. PLOS ONE 15:1, pages e0228472.
Crossref
Crossref
Ploypun Narindrarangkura, William Bosl, Ram Rangsin & Panadda Hatthachote. (2019) Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. Lipids in Health and Disease 18:1.
Crossref
Crossref
Yundai Chen, Zuyi Yuan, Juming Lu, Freddy G. Eliaschewitz, Alberto J. Lorenzatti, Maria Laura Monsalvo, Nan Wang, Andrew W. Hamer & Junbo Ge. (2019) Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial. Diabetes, Obesity and Metabolism 21:6, pages 1464-1473.
Crossref
Crossref
Sheng-Na Han, Wei-Hong Yang, Jian-Jian Yin, Hai-Long Tao & Li-Rong Zhang. (2019) Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination. American Journal of Cardiovascular Drugs 19:3, pages 237-247.
Crossref
Crossref
Ting-Hsing Chao, Pi-Jung Hsiao, Ming-En Liu, Chiung-Jen Wu, Fu-Tien Chiang, Zhih-Cherng Chen, Ching-Pei Chen, Hung-I Yeh, Tsong-Hai Lee & Chern-En Chiang. (2019) A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab. Journal of the Chinese Medical Association 82:4, pages 265-271.
Crossref
Crossref
Sang-Hak Lee, Woo-Hyuk Song, Myung Ho Jeong, Seung-Ho Hur, Dong Woon Jeon, Wonju Jeung, Anselm K Gitt, Martin Horack, Ami Vyas, Dominik Lautsch, Baishali Ambegaonkar, Philippe Brudi & Yangsoo Jang. (2019) Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea. Journal of Lipid and Atherosclerosis 8:2, pages 242.
Crossref
Crossref
Yun Wang, Bryan Ping Yen Yan, Brian Tomlinson, Michael Bruce Nichol & Vivian Wing Yan Lee. (2018) Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention. Journal of Atherosclerosis and Thrombosis 25:12, pages 1255-1273.
Crossref
Crossref
Cho-Kai Wu, Jyh-Ming Jimmy Juang, Jiun-Yang Chiang, Yi-Heng Li, Chia-Ti Tsai & Fu-Tien Chiang. (2018) The Taiwan Heart Registries. Journal of the American College of Cardiology 71:11, pages 1273-1283.
Crossref
Crossref
Saurabh P. Nagar, Pratik P. RaneKathleen M. Fox, Juliana Meyers, Keith Davis, Anne BeaubrunHyoe InomataYi QianKouji Kajinami. (2018) Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy. Circulation Journal 82:4, pages 1008-1016.
Crossref
Crossref
Bambang Dwiputra, Anwar Santoso & Kian K. Poh. (2017) Targeting pro-protein convertase subtilisin kexin-9 as a novel therapy of hypercholesterolemia. Medical Journal of Indonesia 26:2, pages 152-7.
Crossref
Crossref
Na-Qiong Wu, Yuan-Lin Guo, Ping Ye, Hong Chen, Yan-Fang Li, Qi Hua, Cheng-Gang Zhu, Ying Gao, Ping Qing, Xiao-Lin Li, Yao Wang, Geng Liu, Qian Dong & Jian-Jun Li. (2017) Statins usage and target achievement of LDL-C level in Chinese patients with coronary artery disease impacted by 2013 ACC/AHA cholesterol guideline. IJC Metabolic & Endocrine 14, pages 33-37.
Crossref
Crossref
N. C. Tan, C. C. Goh, S. C. P. Goh, Y. L. E. Koh & K. H. Koh. (2016) The effect of the intensity of lipid-lowering medications on the LDL cholesterol treatment goals of Asian patients with dyslipidaemia in primary care. Journal of Clinical Pharmacy and Therapeutics 41:6, pages 677-683.
Crossref
Crossref
Juliana C. N. Chan, Alice P. S. Kong, Weihang Bao, Rana Fayyad & Rachel Laskey. (2016) Safety of atorvastatin in Asian patients within clinical trials. Cardiovascular Therapeutics 34:6, pages 431-440.
Crossref
Crossref
Michael M. Mendelson, Todd Regh, James Chan, Annette Baker, Heather Harker Ryan, Nicole Palumbo, Philip K. Johnson, Suzanne Griggs, Meera Boghani, Nirav K. Desai, Elizabeth Yellen, Lucy Buckley, Matthew W. Gillman, Justin P. Zachariah, Dionne Graham & Sarah D. de Ferranti. (2016) Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia. The Journal of Pediatrics 178, pages 149-155.e9.
Crossref
Crossref
P Yan, EK Tan, JC Choo, CF Liew, T Lau & DD Waters. (2016) Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective. Singapore Medical Journal 57:07, pages 360-367.
Crossref
Crossref
H.-S. Kim, H. Kim, H. Lee, B. Park, S. Park, S.-H. Lee, J. H. Cho, H. Song, J. H. Kim, K.-H. Yoon & I. Y. Choi. (2016) Analysis and comparison of statin prescription patterns and outcomes according to clinical department. Journal of Clinical Pharmacy and Therapeutics 41:1, pages 70-77.
Crossref
Crossref
Chern-En Chiang, Jean Ferrières, Nina N Gotcheva, Frederick J Raal, Abdulla Shehab, Jidong Sung, Karin M Henriksson & Michel P Hermans. (2016) Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). Journal of Atherosclerosis and Thrombosis 23:5, pages 567-587.
Crossref
Crossref
Dan Atar, Seleen Ong & Peter J Lansberg. (2015) Expanding the Evidence Base. American Journal of Therapeutics 22:5, pages e141-e150.
Crossref
Crossref
Li-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, Wei-Kung Tseng, Yen-Wen Wu, I-Chang Hsieh, Tsung-Hsien Lin, Yi-Heng Li, Lien-Chi Huang, Kuo-Yang Wang, Kwo-Chang Ueng, Ching-Chang Fang, Wen-Harn Pan, Hung-I Yeh, Chau-Chung Wu & Jaw-Wen Chen. (2015) Determinants for Achieving the LDL-C Target of Lipid Control for Secondary Prevention of Cardiovascular Events in Taiwan. PLOS ONE 10:3, pages e0116513.
Crossref
Crossref
Chia-Hsuin Chang, Jou-Wei Lin, Chin-Hsien Lin, Hsi-Chieh Chen, Juey-Jen Hwang & Mei-Shu Lai. (2015) Effectiveness and safety of extracranial carotid stent placement: A nationwide self-controlled case-series study. Journal of the Formosan Medical Association 114:3, pages 274-281.
Crossref
Crossref
Ying-Chun Li & Wei-Ling Huang. (2015) Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study. BioMed Research International 2015, pages 1-8.
Crossref
Crossref
S. Unniachan, L. D. Bash, W. Khovidhunkit, R. Z. T. Sri, E. Vicaldo, C. RectoIIII & B. M. Ambegaonkar. (2014) Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries. International Journal of Clinical Practice 68:8, pages 1010-1019.
Crossref
Crossref
Ko-Fan Wang, Chun-Chin Chang, Kang-Ling Wang, Cheng-Hsueh Wu, Lung-Ching Chen, Tse-Min Lu, Shing-Jong Lin & Chern-En Chiang. (2014) Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey. Journal of the Chinese Medical Association 77:2, pages 61-67.
Crossref
Crossref
Kang-Ling Wang, Chia-Jen Liu, Tze-Fan Chao, Su-Jung Chen, Cheng-Hsueh Wu, Chi-Ming Huang, Chun-Chin Chang, Ko-Fan Wang, Tzeng-Ji Chen, Shing-Jong Lin & Chern-En Chiang. (2014) Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy. The American Journal of Cardiology 113:4, pages 631-636.
Crossref
Crossref
Kang-Ling Wang, Cheng-Hsueh Wu, Ko-Fan Wang, Chun-Chin Chang, Lung-Ching Chen, Tse-Min Lu, Shing-Jong Lin & Chern-En Chiang. (2014) The Association between Low-Density Lipoprotein Cholesterol Goal Attainment, Physician and Patient Attitudes and Perceptions, and Healthcare Policy. Journal of Atherosclerosis and Thrombosis 21:10, pages 1044-1054.
Crossref
Crossref
Chun-Yen Chen, Shao-Yuan Chuang, Ching-Chang Fang, Lien-Chi Huang, I-Chang Hsieh, Wen-Harn Pan, Hung-I Yeh, Chau-Chung Wu, Wei-Hsien Yin & Jaw-Wen Chen. (2014) Gender Disparities In Optimal Lipid Control Among Patients with Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis, pages S20-S28.
Crossref
Crossref
Wichai Aekplakorn, Surasak Taneepanichskul, Pattapong Kessomboon, Virasakdi Chongsuvivatwong, Panwadee Putwatana, Piyamitr Sritara, Somkiat Sangwatanaroj & Suwat Chariyalertsak. (2014) Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009. Journal of Lipids 2014, pages 1-13.
Crossref
Crossref
Chin Meng Khoo, Maudrene LS Tan, Yi Wu, Daniel CH Wai, Tavintharan Subramaniam, E Shyong Tai & Jeannette Lee. (2013) Prevalence and Control of Hypercholesterolaemia as Defi ned by NCEP-ATPIII Guidelines and Predictors of LDL-C Goal Attainment in a Multi-Ethnic Asian Population. Annals of the Academy of Medicine, Singapore 42:8, pages 379-387.
Crossref
Crossref
Fei Gao, Yu Jie Zhou, Da Yi Hu, Ying Xin Zhao, Yu Yang Liu, Zhi Jian Wang, Shi Wei Yang & Xiao Li Liu. (2013) Contemporary Management and Attainment of Cholesterol Targets for Patients with Dyslipidemia in China. PLoS ONE 8:4, pages e47681.
Crossref
Crossref
최선, 이수경, 나현오, 박은하, 한옥연 & 황유경. (2013) Drug Use Evaluation of Statins Focused on Drug-Drug Interactions. Journal of Korean Society of Health-System Pharmacists 30:2, pages 95-107.
Crossref
Crossref
Tun-Ying Hsu, Diana Chirovsky, Foong Ming Moy & Baishali M. Ambegaonkar. (2013) Attainment of Goal and Normalized Lipid Levels With Lipid-Modifying Therapy in Malaysia. Clinical Therapeutics 35:4, pages 450-460.
Crossref
Crossref
Calvin W ChinF GaoTT LeRS Tan. (2013) Lipid Goal Attainment and Prescription Behavior in Asian Patients with Acute Coronary Syndromes: Experience from a Tertiary Hospital. Clinical Medicine Insights: Cardiology 7, pages CMC.S11488.
Crossref
Crossref
Rui Zhang, Liancheng Zhao, Lirong Liang, Gaoqiang Xie & Yangfeng Wu. (2012) Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy. Lipids in Health and Disease 11:1.
Crossref
Crossref
Chern-En Chiang & Kang-Ling Wang. (2012) Unmet needs of diabetic patients. Journal of the Chinese Medical Association 75:12, pages 615-616.
Crossref
Crossref
Wei-Hsian Yin, Chau-Chung Wu & Jaw-Wen Chen. (2012) Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods. International Journal of Gerontology 6:4, pages 241-246.
Crossref
Crossref
Alfred Penfornis, Alain Baleydier, Thierry Clavel & Sylvie Picard. (2012) LDL-cholesterol target values and actual values in patients with type 2 diabetes (T2D) uncontrolled on oral antidiabetic monotherapy: The lipid results of the French ESCALADE survey. Annales d'Endocrinologie 73:6, pages 503-509.
Crossref
Crossref
Peter H. Jones, Radhika Nair & Kamlesh M. Thakker. (2012) Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin‐Treated Subjects From 3 Data Sources: A Retrospective Analysis. Journal of the American Heart Association 1:6.
Crossref
Crossref
Weerapan Khovidhunkit, Songkwan Silaruks, Vithaya Chaithiraphan, Boonsong Ongphiphadhanakul, Piyamitr Sritara, Hataikarn Nimitphong, Thanawat Benjanuwattra & Baishali M. Ambegaonkar. (2012) Prevalence of Dyslipidemia and Goal Attainment After Initiating Lipid-Modifying Therapy. Angiology 63:7, pages 528-534.
Crossref
Crossref
Kang-Ling Wang, Chia-Jen Liu, Tze-Fan Chao, Chi-Ming Huang, Cheng-Hsueh Wu, Su-Jung Chen, Tzeng-Ji Chen, Shing-Jong Lin & Chern-En Chiang. (2012) Statins, Risk of Diabetes, and Implications on Outcomes in the General Population. Journal of the American College of Cardiology 60:14, pages 1231-1238.
Crossref
Crossref
Jeong Euy ParkChern-En ChiangMuhammad MunawarGia Khai PhamApichard SukonthasarnAnastacio R AquinoKah Lin KhooHon Wah Raymond Chan. (2011) Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey. European Journal of Preventive Cardiology 19:4, pages 781-794.
Crossref
Crossref
Yuan-Lin Guo, Jun Liu, Jian-Jun Li, Cheng-Gang Zhu, Ping Qing, Yan-Jun Jia, Na-Qiong Wu, Shao-Ping Nie, Zi-Cheng Li, He-Song Zeng & Ping Yang. (2011) A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery disease in real world cardiovascular practice. International Journal of Cardiology 153:2, pages 211-212.
Crossref
Crossref
Ping Wang. (2011) Statin dose in Asians: is pharmacogenetics relevant?. Pharmacogenomics 12:11, pages 1605-1615.
Crossref
Crossref
Juliana C.N. Chan, Siew Pheng Chan, Chaicharn Deerochanawong, Ruby T. Go, Kok-Onn Lee, Ronald Ching-Wan Ma, Chang-Yu Pan, Wayne H-H. Sheu & Philip Barter. (2011) Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don’t know. Diabetes Research and Clinical Practice 94:1, pages 1-13.
Crossref
Crossref
John Reckless, Glenn Davies, Kaan Tunceli, X. Henry Hu & Philippe Brudi. (2010) Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study. Value in Health 13:6, pages 726-734.
Crossref
Crossref
Danny Liew, Hye-Jin Park & Su-Kyoung Ko. (2009) Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. Clinical Therapeutics 31:10, pages 2189-2203.
Crossref
Crossref